Evaluation of Anti-Urolithiatic activity of Bougainvillea spectabilis Wild. Against Sodium Oxalate-Induced nephrolithiasis in rats
Abstract
As there is no effective treatment for kidney stones, the development and progression of renal calculi continue to be a cause for concern despite developments in contemporary medicine. In the current study, the anti-urolithiasis activity of Bougainvillea spectabilis Willd. against sodium oxalate (NaOx)-induced urolithiasis in rats was studied. Leaves of B. spectabilis were extracted with various solvents, i.e., petroleum ether, chloroform, ethyl acetate, ethanol, and water. Albino wistar male rats were divided into five groups of six animals each. All groups except the positive control were treated intraperitoneally with sodium oxalate (70 mg/kg) for 10 days. Treatment with the standard drug cystone (5 mL/kg), ethanol, and aqueous extracts (200 mg/kg) was given to the respective groups for 10 days of study. On the 10th day, serum creatinine, calcium, uric acid, blood urea nitrogen, urine calcium, oxalate, and uric acid levels were estimated, along with urine microscopy to confirm crystals. Kidneys were isolated and used for histopathological studies. The results suggested that the administration of B. spectabilis to rats with sodium oxalate-induced lithiasis reduced and prevented the formation of urinary stones. Also, the treatment of lithiasis-induced rats with the toxic control drug and extracts of B. spectabilis restored all the elevated urine and serum biochemical parameters, including creatinine, calcium, oxalate, uric acid, and blood urea nitrogen, and significantly increased the urine volume. The histopathology showed depositions of a large number of calcium oxalate crystals in the kidney in the calculi-induced group with enlargement of glomeruli and necrosis of tubules, while in the standard and extract-treated groups, small and fewer deposits were seen with the recovered architecture of the kidney tubules. The result indicates the anti-urolithiasis activity of B. spectabilis mediated possibly by the presence of flavonoids, calcium oxalate crystal inhibitors, and antioxidant properties which maintain the balance between stone promoters and inhibitors constituents and this study rationalized its medicinal use in urolithiasis.
Keywords:
Bougainvillea Spectabilis, flavonoids, oxalate, sodium oxalate, UrolithiasisDOI
https://doi.org/10.25004/IJPSDR.2023.150109References
Mohamed N, Farook P, Mozhiyarasi and Nalini R. Inhibition of Mineralization of Urinary Stone Forming Minerals by Medicinal Plants. E-Journal of Chemistry 2006; 3: 182-5.
Gangwal K. Current concepts on aetiology of urolithiasis. 1971; 8:58.
Singh P, Singh L, Prasad S, Singh M. Urolithiasis in Manipur (North Eastern Region of India). Incidence and chemical composition of stones. Am J Clin Nutr 1978; 31: 1519-25.
Preminger G. Management of lower pole renal calculi: Shock Wave Lithotripsy versus Percutaneous Nephrolithotomy versus Flexible Ureteroscopy. Urol Res 2006; 34: 108-11.
Nabi G, Downey P, Keeley FX, Watson GM, McClinton S. Extracorporeal shock wave lithotripsy (ESWL) versus ureteroscopic management for ureteric calculi. Cochrane Database Syst Rev. 2012; 5 :1095-103.
Aeckart KSJ, Schroder FH. Effect of extra corporeal shock wave lithotripsy (ESWL) on renal tissue. Urol Res. 1989; 17(1):3-7.
Mahajan MM, Dudhgaonkar S, Deshmukh SN. Anti-diabetic and hypolipidemic effects of the aqueous leaf extract of Bougainvillea species. Int J Basic Clin Pharmacol 2015; 4:596-7.
Rashid F, Sharif N, Ali I, Sharif S, Nisa FU, Naz S. Phytochemical analysis and inhibitory activity of ornamental plant (Bougainvillea spectabilis). Asian J Plant Sci Res 2013; 3:1-5.
Umamaheswari A, Shreevidya R, Nuni A. In vitro antibacterial activity of Bougainvillea spectabilis leaves extracts. Adv Biol Res 2008; 2:1-5.
Kumara Swamy M, Sudipta KM, Lokesh P, Neeki MA, Rashmi W, Bhaumik SH, Phytochemical screening and in vitro antimicrobial activity of Bougainvillea spectabilis flower extracts. Int J Phytomed 2012; 4:375-9.
Hajare CN, Inamdar FR, Patil RV, Shete CS, Wadkar SS, Patil KS, et al. Antibacterial activity of the leaves of Bougainvillea spectabilis against E. coli NCIM 2832 and M. aureus NCIM 5021. Int J Pharm Sci Rev Res 2015; 34:194-6.
Kumar DJ, Sonia K, Madhan R, Selvakumar K. Antiyeast, antioxidant and anticancer activity of Tribulus terrestris Linn and Bougainvillea spectabilis Linn. Res J Pharm Technol 2011;4:1483-9.
Narayanan CR, Joshi DD, Mujumdar AM. Hypoglycemic action of Bougainvillea spectabilis leaves. Curr Sci 1984; 53:579-81.
Saikia H, Das S. Antidiabetic action of Bougainvillea spectabilis (leaves) in normal and alloxan induced diabetic albino rats. Indian Drugs 2009;46: 391-7.
Jawla S, Kumar Y, Khan MS. Hypoglycemia activity of Bougainvillea spectabilis stem bark in normal and alloxan-induced diabetic rats. Asian Pac J Trop Biomed 2012;2:919-23.
Mishra N, Joshi S, Tandon VL, Munjal A. Evaluation of antifertility potential of aqueous extract of Bougainvillea spectabilis leaves in swiss albino mice. Int J Pharm Sci Drug Res. 2009;1: 19-23.
Hembrom AR, Pragya S, Kumar J, Singh VN. Effects of aqueous leaf extract of Bougainvillea spectabilis on seminal quality of mice. J Adv Zool. 2011; 32:119-22.
Ali MS, Ibrahim SA, Ahmed F, Pervez MK. Colour versus bioactivity in the flowers of Bougainvillea spectabilis (Nyctaginaceae). Nat Prod Res. 2005; 19:1-5.
Joshi DD, Mujumdar AM, Narayanan CR. Anti-inflammatory activity of Bougainvillea spectabilis leaves. Indian J Pharm Sci. 1984; 46:187-8.
Mandal G, Chatterjee C, Chatterjee M. Evaluation of anti-inflammatory activity of methanolic extract of leaves of Bougainvillea spectabilis in experimental animal models. Pharmacogn Res 2015; 7:18-22.
Adebayo JO, Adesokan AA, Olatunji LA, Buoro DO, Aoladoye AO. Effect of ethanolic extract of Bougainvillea spectabilis leaves on haematological and serum lipid variables in rats. Biochemistry 2005; 17:45-50.
Saikia H, Lama A. Effect of Bougainvillea spectabilis leaves on serum lipids in albino rats fed with high fat diet. Int J Pharm Sci Drug Res 2011; 3:141-5.
Chaires-Martinez L, Monroy-Reyes E, Bautista-Bringas A, Jimenez-Avalos HA, Sepulveda-Jimenez G. Determination of radical scavenging activity of hydroalcoholic and aqueous extracts from Bauhinia divaricata and Bougainvillea spectabilis using the DPPH assay. Pharmacognosy Res. 2009; 1:238-44.
Venkatachalam RN, Singh K, Marar T. Bougainvillea spectabilis, a good source of antioxidant phytochemicals. Res J Pharm Biol Chem Sci. 2012;3: 605-13.
Dhankhar S, Sharma M, Ruhil S, Balhara M, Kumar M, Chhillar AK. Evaluation of antimicrobial and antioxidant activities of Bougainvillea spectabilis. Int J Pharm Pharm Sci. 2013;5:178-82.
Malairajan P, Gopalakrishnan G, Narasimhan S, Jessi KV. Antiulcer activity of crude alcoholic extracts of Bougainvillea spectabilis Willd. Jundishapar J Nat Pharm Prod. 2007;2:1-6.
Bolognesi A, Polito L, Olivieri F, Valbonesi P, Barbieri L, Battelli MG, et al. New ribosome-inactivating proteins with polynucleotide:adenosine glycosidase and antiviral activities from Basella rubra L. and Bougainvillea spectabilis Willd. Planta 1997; 203: 422-9.
Malomo SO, Adebayo JO, Arise RO, Olorunniji FJ, Egwim EC. Effects of ethanolic extract of Bougainvillea spectabilis leaves on some liver and kidney function indices in rats. Phytochem Pharmacol 2006; 17:261-72.
Sherwani SK, Khan MM, Zubair A, Shh MA, Kazmi SU. Evaluation of in vitro thrombolytic activity of Bougainvillea spectabilis leaf extract. Int J Pharm Sci Rev Res 2013; 21:6-9.
Srivastava SK, Krishnan PS. An Oxalic Acid Oxidase in the Leaves of Bougainvillea spectabilis. Biochem. J, 1962; 85: 33-38.
Rajeswari. P, Keziya priya, Bhanusree. In Vitro Evaluation of Anti-Urolithiatic Activity of Aqueous Extract of Bougainvillea glabra (Leaves) Ijppr. Human Journals, 2018; Vol. 12 (3): 409-421.
Das et al., Evaluation Of In- Vitro Litholytic Activity of Plant Bougainvillea Spectabilis. J Adv Sci Res, 2021; 12 (4): Suppl 1: 311-315.
Smith QE, Pharmacological screening tests progress in medicinal chemistry, Butterworths, London, 1960; 16: pp. 1-5.
Aisha Shehzad, et al. Antiurolithic Evaluation of Cucurbita pepo Seeds Extract against Sodium Oxalate-Induced Renal Calculi. Pharmacognosy Magazine, Volume 16, Issue 68, January-March 2020 (Supplement 1).
Hodgkinson A. Determination of oxalic acid in biological material. Clin. Chem. (1970); 16: 547.
Lorentz K. Improve determination of calcium with ortho-cresolphthalein complexone. Clin Chim Acta 1982; 126: 327-33.
Das P, Vaghela J, Badore N, Pharmacognostical, Phytochemical and Fluorescence analysis of the plant Bougainvillea spectabilis (Willd.). Research J. Pharm. and Tech.2021; 14(7): 3733-3738.
Gupta P, Patel N, Bhatt L, et al. Anti-urolithiatic effect of petroleum ether extract stem bark of Crataeva adansonii in rats. Pharm Biol. 2006; 44: 160-165.
Takawale RV, Mali VR, Kapase CU, et al. Effect of Lagenaria siceraria fruit powder on sodium oxalate induced urolithiasis in Wistar rats. J Ayurveda Integr Med. 2012; 3:75-79.
Patel N, Badole S, Gupta P, et al. Effect of ethanolic extract of leaves of Cocculus hirsutus (L.) diels on experimentally induced urothiliasis in rats. J Nat Rem. 2008;8:24-31.
Scheid CR, Cao LC, HoneymanT,. How elevated oxalate can promote kidney stone disease: changes at the surface and in the cytosol of renal cells that promote crystal adherence and growth? Front Biosci. 2004; 9:797-808.
Karadi RV, Gadge NB, Alagawadi KR. Effect of Moringa oleifera Lam. Rootwood on ethylene glycol induced urolithiasis in rats. J Ethnopharmacol. 2006; 105: 306-311.
Ingale KG, Thakurdesai PA, Vyawahare NS. Effect of Hygrophila spinosa in ethylene glycol induced nephrolithiasis in rats. Indian J Pharmacol. 2012; 44: 639-642.
Divakar K, Pawar AT, Chandrasekhar SB, et al. Protective effect of the hydroalcoholic extract of Rubia cordifolia roots against ethylene glycol induced urolithiasis in rats. Food Chem Toxicol. 2010;48:1013-1018.
Grases F, Gil JJ, Conte A. Glycosaminoglycans: inhibition of calcium oxalate crystalline growth and promotion of crystal aggregation. Colloids Surfaces. 1989; 36:29-38.
Published

